Report
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response
| العنوان: | Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response |
|---|---|
| المصدر: | A Phase I/II Trial of ACA 125 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer Pfisterer J, du Bois A, Sehouli J, Loibl S, Reinartz S, Reuss A, Canzler U, Belau A, Jackisch C, Kimmig R, Wollschlaeger K, Heilmann V, Hilpert F. The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR. Ann Oncol. 2006 Oct;17(10):1568-77. doi: 10.1093/annonc/mdl357. |
| قاعدة البيانات: | ClinicalTrials.gov |
| الوصف غير متاح. |